Related references
Note: Only part of the references are listed.Baseline Sympathetic Nervous System Activity Predicts Dietary Weight Loss in Obese Metabolic Syndrome Subjects
Nora E. Straznicky et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Obesity is associated with fatal coronary heart disease independently of traditional risk factors and deprivation
Jennifer Logue et al.
HEART (2011)
Metabolic sequelae of β-blocker therapy: weighing in on the obesity epidemic?
P. Lee et al.
INTERNATIONAL JOURNAL OF OBESITY (2011)
Single-unit muscle sympathetic nervous activity and its relation to cardiac noradrenaline spillover
Elisabeth A. Lambert et al.
JOURNAL OF PHYSIOLOGY-LONDON (2011)
Sympathetic Nervous System Activity Is Associated With Obesity-Induced Subclinical Organ Damage in Young Adults
Elisabeth Lambert et al.
HYPERTENSION (2010)
Association between the sympathetic firing pattern and anxiety level in patients with the metabolic syndrome and elevated blood pressure
Elisabeth Lambert et al.
JOURNAL OF HYPERTENSION (2010)
Sympathetic nervous activation in obesity and the metabolic syndrome-Causes, consequences and therapeutic implications
Gavin W. Lambert et al.
PHARMACOLOGY & THERAPEUTICS (2010)
Blunted sympathetic neural response to oral glucose in obese subjects with the insulin-resistant metabolic syndrome
Nora E. Straznicky et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2009)
Weight Loss May Reverse Blunted Sympathetic Neural Responsiveness to Glucose Ingestion in Obese Subjects With Metabolic Syndrome
Nora E. Straznicky et al.
DIABETES (2009)
Sympathetic Activation in Chronic Renal Failure
Markus P. Schlaich et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Renal Sympathetic-Nerve Ablation for Uncontrolled Hypertension.
Markus P. Schlaich et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Mediators of Sympathetic Activation in Metabolic Syndrome Obesity
Nora E. Straznicky et al.
CURRENT HYPERTENSION REPORTS (2008)
Impact of Obesity on Cardiovascular Disease
Kerstyn C. Zalesin et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2008)
Differing pattern of sympathoexcitation in normal-weight and obesity-related hypertension
Elisabeth Lambert et al.
HYPERTENSION (2007)
Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome
Lydia E. Kuo et al.
NATURE MEDICINE (2007)
Moxonidine - A review of its use in essential hypertension
C Fenton et al.
DRUGS (2006)
Effects of dietary weight loss on sympathetic activity and cardiac risk factors associated with the metabolic syndrome
NE Straznicky et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Obstructive sleep apnea-dependent and -independent adrenergic activation in obesity
G Grassi et al.
HYPERTENSION (2005)
Subcutaneous obesity is not associated with sympathetic neural activation
GE Alvarez et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2004)
Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation
K Masuo et al.
HYPERTENSION (2003)
Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy
MP Schlaich et al.
CIRCULATION (2003)
Antihypertensive effect of α- and β-adrenergic blockade in obese and lean hypertensive subjects
MR Wofford et al.
AMERICAN JOURNAL OF HYPERTENSION (2001)
Share Paper
